Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Tracey Lodie"'
Autor:
GRO Biosciences Inc.
Publikováno v:
Business Wire (English). 03/18/2024.
Autor:
Frank Cichocki, Aviad Pato, Astar Hailu, Nurit Brickman, Dima Yackoubov, Amnon Peled, Ronit Simantov, Tracey Lodie, Julia Rifman, Yona Geffen, Orit Berhani-Zipori, Avishay Edri
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/74a695a39bdc44b39ba9d04f8c9baba2
Autor:
Aviad Pato, Astar Hailu, Dima Yackoubov, Tracey Lodie, Julia Rifman, Yona Geffen, Orit Berhani-Zipori, Avishay Edri, Sherri Cohen, Nurit Brycman, Boaz Buhandler, Moshe Shahor, Nathan Dinowitz, Amram Ben David, Avi Izraeli, Vered Chalifa-Caspi, Liron Levin, Joshua Rabinowitz, Wenyun Lu, Julian Adams
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/8889d445cfab470199a0ade425708109
Autor:
PR Newswire
Publikováno v:
PR Newswire US. 07/29/2021.
Autor:
Liron Levin, Julian Adams, Nurit Brycman, Julia Rifman, Dima Yackoubov, Vered Chalifa-Caspi, Sherri Cohen, Aviad Pato, Joshua D. Rabinowitz, Yona Geffen, Avi Izraeli, Astar Hailu, Tracey Lodie, Nathan Dinowitz, Amram Ben David, Orit Berhani-Zipori, Moshe Shahor, Avishay Edri, Wenyun Lu, Boaz Buhandler
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundNicotinamide (NAM), an allosteric inhibitor of NAD-dependent enzymes, has been shown to preserve cell function and prevent differentiation in ex vivo cell culture. GDA-201 is an investigational natural killer (NK) cell immunotherapy derived
Autor:
Nathan Dinowitz, Nurit Persi, Aviad Pato, Liron Levin, Orit Berhani-Zipori, Moshe Shahor, Joshua D. Rabinowitz, Frank Cichocki, Julian Adams, Dima Yackoubov, Sherri Cohen, Boaz Buhandler, Amnon Peled, Yona Geffen, Ronit Simantov, Julia Rifman, Amram Ben David, Melanie R. McReynolds, Astar Hailu, Avishai Edri, Vered Caspi, Tracey Lodie, Avi Izraeli, Wenyun Lu
Publikováno v:
Transplantation and Cellular Therapy. 28:S214-S215
Adoptive transfer of NK cells is a promising immunotherapeutic modality, however limited NK cell persistence and proliferation in vivo have historically been barriers to clinical success. Nicotinamide (NAM), an allosteric inhibitor of NAD-dependent e
Autor:
Tracey Lodie, Veronika Bachanova, Frank Cichocki, Murali Janakiram, Joseph Maakaron, Ronit Simantov, David H. McKenna, Rose Wangen, Qing Cao, Todd E. DeFor, Bartosz Grzywacz, Zuzan Cayci, Jeffrey S. Miller
Publikováno v:
Blood. 138:3854-3854
Background: The innate capacity of natural killer (NK) cells to kill tumor targets has been translated into cancer immunotherapy. GDA-201 represents a novel class of metabolically enhanced ex-vivo expanded allogeneic NK cells with acquired capacity f
Autor:
Dima Yackoubov, Julian Adams, Alina Maliutina, Tracey Lodie, Vered Caspi, Yair Steinhardt, Boaz Buhenvald, Nathan Dinowitz, Dorit Ashengrau, Moshe Shahor, Amnon Peled, Sherry Cohen, Adi Bitansky, Tony Peled
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S258-S259
Historical efforts at expansion of umbilical cord blood (UCB) derived CD34+ hematopoietic stem cells (HSCs) ex vivo with cytokines yielded large numbers of progenitors for transplantation but impaired their long-term engraftment ability. We used nico
Autor:
Murali Janakiram, Qing Cao, Rose Wangen, Bartosz Grzywacz, Fiona He, Todd E. DeFor, Ronit Simantov, David H. McKenna, Joseph Maakaron, Zuzan Cayci, Tracey Lodie, Veronika Bachanova, Jeffrey S. Miller
Publikováno v:
Blood. 136:6-6
Background: The innate capacity of natural killer (NK) cells to kill tumor targets has been translated into cancer immunotherapy. GDA-201 is a novel allogeneic NK cell product derived from NK cells from healthy donors, expanded ex-vivo with nicotinam
Autor:
Matthew L. Eaton, Tracey Lodie, Christian Fritz, Michael R. McKeown, Chris Fiore, Emily Lee, Eric N. Olson, Darren Smith, Kathryn Austgen
Publikováno v:
Cancer Research. 77:2644-2644
CD38 is a cell surface protein expressed primarily on white blood cells and considered a marker of differentiation initiation. CD38 is involved in the immune system by engaging cross-talk with T and B cells as well as activation of NK cells. In multi